What is driving the growth of the intravenous solutions market? The intravenous (IV) solutions market is witnessing strong growth, driven by rising chronic disease prevalence, hospitalizations, and demand for advanced drug-delivery and nutritional therapies. Valued at USD 13.03 billion in 2024, the market is expected to reach USD 26.12 billion by 2034, growing at a CAGR of 7.20%. The Middle...